The identification of temporal trends in the incidence of disease or in the phenotypic characteristics of complex diseases such as multiple sclerosis (MS) over short time intervals may lead to the recognition of contributing environmental factors. In recent years, investigators have reported a rising incidence of MS in some world regions, an increasing female:male sex ratio, and a progressively earlier age of symptom onset. 1 However, analyses of temporal trends can suffer from multiple biases, leading to erroneous conclusions as previously reported for age of onset. 2, 3 In this issue of Multiple Sclerosis Journal, Westerlind et al. examined temporal trends in the diagnosis of primary progressive multiple sclerosis (PPMS). They used the Swedish MS registry to identify 16,915 persons with MS, representing six birth cohorts and seven date of diagnosis cohorts . 4 They found that the proportion of persons with PPMS at onset decreased from 19.2% in the 1946-1950 birth cohort to 2.2% in the 1971-1975 birth cohort, a remarkable decline. The authors have thoughtfully attempted to address many of the potential biases that might account for this result, including survival bias, inadequate duration of follow-up in younger birth cohorts, and the effects of changing diagnostic criteria. Nevertheless, it remains difficult to accept this rapid decline in the occurrence of PPMS, and this may reflect incomplete control of these biases, which work together in complex ways.
First, survival bias is probably operating as evidenced by the older average age of onset of 46.3 in the persons with PPMS in the oldest birth cohort consistent with frequently reported age at onset as compared to 34.6 years in the youngest birth cohort. The average age at onset also declined in the relapsing-onset cohorts, from 38.4 in the oldest cohort to 29.8 in the youngest. This also illustrates a potential survivorship bias that may or may not be the same as that in the PPMS cohort.
Second, the exclusion of the large proportion of unclassified patients (8.6%), a proportion nearly as large as those identified with PPMS (8.6%), may influence the results. This may have contributed differentially to reducing the denominator over time, impacting their findings. We note that one of the sensitivity analyses combined the two groups which greatly reduced the incidence rate ratio to 0.89.
Finally, and perhaps most importantly, the inadequate and differential duration of follow-up by birth cohort may lead to a substantial overestimate of the decline in the proportion of PPMS. Consider the fact that the mean age at diagnosis for the 1945 birth cohort was 46.3. The current maximum age for the youngest cohort is 41-45 in 2016 showing that the younger birth cohorts are missing the older persons who get diagnosed with MS because they have not been diagnosed yet, thus the differential follow-up time truncates the period over which to make the diagnosis within a birth cohort, affecting the prevalence in the cohorts.
Consider a simple mathematical example to illustrate the effect of these issues. Suppose we have 1000 MS patients in each birth cohort and we estimate the proportion with PPMS to be 10% for each of those birth cohorts. Therefore, each birth cohort would include 100 PPMS and 900 relapsing-onset multiple sclerosis (ROMS) patients. We will adjust these numbers for deaths, which decline by birth cohort; for the followup time, which reduces the prevalence of PPMS in the cohort; and, finally, for the elimination of the unclassified group from the ROMS population. The adjustments have been informed by the literature, but are only meant to illustrate how such assumptions and estimates combine to produce remarkable declines in the prevalence of PPMS as shown in Table 1 of the Westerlind article.
We assumed that 30% of the 1946-1950 birth cohort will have died by 2016, based on findings from the
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North American Research Committee on Multiple Sclerosis (NARCOMS) registry. 5 This registry also includes a survival bias because they have to survive to register, but nevertheless is probably sufficient for our example. We assumed this mortality declines by 5% per year per birth cohort. We assumed that all of the oldest cohort would have been fully diagnosed with MS by a mean age of 68 years in 2016. This diagnosis rate declines to 95% of the cohort with an average age of 63 years, to 90% for those whose average age is 58 years, to 80% for those aged 53 years, to 50% for those aged 48 years, as several sources (refs) indicate the average age of PPMS onset in patients is about 46 years, and finally to 20% who are diagnosed among those with an average age of 43 years since they are below the average age of prevalent PPMS populations. 6, 7 We next hypothesize that relapsing-onset cases would be overrepresented in the unclassified pool of patients and thus we remove some of these from each denominator of each birth cohort. We remove 35% in the oldest cohort and decline this rate by 5% in each subsequent birth cohort. Table 2 shows the successive adjustments to the numerator (shaded cells) and denominator (white cells). In the column for Rate 1 (blue cells), this adjustment includes a reduction in both numerator and denominator for deaths and an adjustment for elimination from the non-primary progressive MS (PPMS) population of unclassified patients who may have relapsing onset MS (ROMS). Rate 2 adjusts the components used in Rate 1 for the fraction of PPMS cases left undiagnosed due to truncation of the time of follow-up that is insufficient to capture all such cases due to a delayed date of onset or diagnosis. What results in the final column of Table  2 are rates that mimic the reported declines in Table 1 of the Westerlind paper of 18.2%-3.4%. This hypothetical analysis makes multiple assumptions and has not considered all factors relevant to the findings reported by Westerlind et al. Nevertheless, it suggests that the findings should be interpreted cautiously, as should any reported temporal trends in the phenotype of MS. PPMS is not on its way to extinction and efforts to understand the differences in the origins of PPMS and ROMS are still needed.
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